Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Cancer Immunology, Immunotherapy : CII|March 17, 2015
Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological responseNaoya Hashimoto, Akihiro Tsuboi, Naoki Kagawa, et al.
Neuro-Oncology Advances|August 6, 2021
Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapiesChisato Yokota, Jun Nakata, Koji Takano, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|February 7, 2026
Accurate classification of ependymomas and medulloblastomas using Raman spectroscopy and pilot transcriptomic profilingYuki Kawamoto, Yoshiko Okita, Kenta Temma, et al.
Cancer Science|October 5, 2021
Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trialYoshitaka Narita, Yoshihiro Muragaki, Naoki Kagawa, et al.
Cancer Science|June 1, 2021
Determination of brain tumor recurrence using <sup>11</sup> C-methionine positron emission tomography after radiotherapyShigeru Yamaguchi, Kenji Hirata, Michinari Okamoto, et al.
Annals of Nuclear Medicine|August 18, 2021
Determining the extent of tumor resection at surgical planning with <sup>18</sup>F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trialsToshihiko Wakabayashi, Yuichi Hirose, Keisuke Miyake, et al.
Cancer Immunology, Immunotherapy : CII|November 7, 2024
Spontaneous high clonal expansion of Wilms' tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms' tumor gene 1-expressing solid tumorSoyoko Morimoto, Yukie Tanaka, Jun Nakata, et al.
Cancer Science|December 1, 2011
Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donorsSoyoko Morimoto, Yoshihiro Oka, Akihiro Tsuboi, et al.
Acta Neuropathologica Communications|June 20, 2019
Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohortsToru Umehara, Hideyuki Arita, Ema Yoshioka, et al.
Journal of Neurosurgery|May 2, 2008
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiformeShuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, et al.
Pageof 11